「3s」の検索結果
173件：136～140件目を表示
-
Milestones in Our History | About Senju | SENJU Pharmaceutical
1947 Apri Hiroshi Tsuzuki (CEO) established the company in Tennoji-ku, Osaka with start-up capital of 195,000 yen. July Injection Product for Neutropenia, "PANILTIN", sales launched 1949 Feb
https://www.senju.co.jp/english/about/history.html -
Presence of Products | Overseas Activities | SENJU Pharmaceutical
Asia Middle East Europe North&South Ameica Asia Korea Brand Name Marketing Authorisation Holder JP Brand Name BRONUCK Taejoon Pharmaceutical Co., Ltd. BRONUCK ALYMUS Taejoon Pharmaceutical Co., Lt
http://www.senju.co.jp/english/global/world.html -
Overseas Activities | SENJU Pharmaceutical
Eye health and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we ent
http://www.senju.co.jp/english/global/ -
Management Policy | About Senju | SENJU Pharmaceutical
“Being a good company” is our management policy. As a company that aims to be reliable, necessary and valuable for society, we are committed to pursuing happiness for all people associated with Senju
http://www.senju.co.jp/english/about/philosophy.html -
ラタチモ配合点眼液「センジュ」
069-618 FAX 06-6201-0577 受付時間 9：00∼17：30 （土、日、祝日を除く） 26. 製造販売業者等 26. 1 製造販売元 26. 2 販売 分子式：C13H24N4O3S・C4H4O4 分子量：432.49 性 状：チモロールマレイン酸塩は白色∼微黄白色の結晶性の 粉末である。 酢酸 （100） に溶けやすく、水又はエタノール （99.5） に やや溶けやすい。 ...
https://www.senju.co.jp/system/files/product_other_file/2023-01/Latachimo_202302_C7.pdf